Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Tugwell

Showing results (401-410 of 473) with videos related to

Pageof 48
Sort By:
Journal of Clinical Epidemiology|May 2, 2022
A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation mapKevin Pottie, Maureen Smith, Micayla Matthews, et al.
Seminars in Arthritis and Rheumatism|November 2, 2023
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working GroupDorthe B Berthelsen, Lee S Simon, John P A Ioannidis, et al.
Seminars in Arthritis and Rheumatism|November 29, 2021
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working groupMelanie Birger Morillon, Robin Christensen, Jasvinder A Singh, et al.
Journal of Clinical Epidemiology|May 14, 2017
GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklistElie A Akl, Vivian Welch, Kevin Pottie, et al.
The Journal of Rheumatology|April 3, 2014
Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validityPeter Tugwell, Maarten Boers, Maria-Antonietta D'Agostino, et al.
The Journal of Rheumatology|March 4, 2014
Updating the OMERACT filter: implications for patient-reported outcomesJohn R Kirwan, Susan J Bartlett, Dorcas E Beaton, et al.
Seminars in Arthritis and Rheumatism|December 20, 2023
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain setDiego Benavent, Loreto Carmona, Maria A Lopez-Olivo, et al.
Seminars in Arthritis and Rheumatism|August 4, 2014
A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Mickaël Hiligsmann, Cyrus Cooper, Francis Guillemin, et al.
Journal of Clinical Epidemiology|April 17, 2017
GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationaleVivian A Welch, Elie A Akl, Gordon Guyatt, et al.
Clinical Rheumatology|September 8, 2018
Correction to: Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelinesThurayya Arayssi, Manale Harfouche, Andrea Darzi, et al.
Pageof 48

Showing results (401-410 of 473) with videos related to

Sort By:
Pageof 48
Journal of Clinical Epidemiology|May 2, 2022
A multistakeholder development process to prioritize and translate COVID-19 health recommendations for patients, caregivers and the public. A case study of the COVID-19 recommendation mapKevin Pottie, Maureen Smith, Micayla Matthews, et al.
Seminars in Arthritis and Rheumatism|November 2, 2023
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working GroupDorthe B Berthelsen, Lee S Simon, John P A Ioannidis, et al.
Seminars in Arthritis and Rheumatism|November 29, 2021
Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working groupMelanie Birger Morillon, Robin Christensen, Jasvinder A Singh, et al.
Journal of Clinical Epidemiology|May 14, 2017
GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklistElie A Akl, Vivian Welch, Kevin Pottie, et al.
The Journal of Rheumatology|April 3, 2014
Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validityPeter Tugwell, Maarten Boers, Maria-Antonietta D'Agostino, et al.
The Journal of Rheumatology|March 4, 2014
Updating the OMERACT filter: implications for patient-reported outcomesJohn R Kirwan, Susan J Bartlett, Dorcas E Beaton, et al.
Seminars in Arthritis and Rheumatism|December 20, 2023
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain setDiego Benavent, Loreto Carmona, Maria A Lopez-Olivo, et al.
Seminars in Arthritis and Rheumatism|August 4, 2014
A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)Mickaël Hiligsmann, Cyrus Cooper, Francis Guillemin, et al.
Journal of Clinical Epidemiology|April 17, 2017
GRADE equity guidelines 1: considering health equity in GRADE guideline development: introduction and rationaleVivian A Welch, Elie A Akl, Gordon Guyatt, et al.
Clinical Rheumatology|September 8, 2018
Correction to: Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelinesThurayya Arayssi, Manale Harfouche, Andrea Darzi, et al.
Pageof 48